Works about DRUG tolerance

Results: 3487
    1

    GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures.

    Published in:
    Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-025-02068-2
    By:
    • Barbanti, Piero;
    • Egeo, Gabriella;
    • Pistoia, Francesca;
    • Aurilia, Cinzia;
    • Scatena, Paola;
    • Rinalduzzi, Steno;
    • Strumia, Silvia;
    • Salerno, Antonio;
    • Frediani, Fabio;
    • Galli, Andrea;
    • Autunno, Massimo;
    • Di Clemente, Laura;
    • Zucco, Maurizio;
    • Albanese, Maria;
    • Bono, Francesco;
    • Bruno, Pietrantonio;
    • Borrello, Laura;
    • Messina, Stefano;
    • Doretti, Alberto;
    • Ranieri, Angelo
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Efficacy and Tolerability of a Chemically Characterized Scutellaria lateriflora L. Extract-Based Food Supplement for Sleep Management: A Single-Center, Controlled, Randomized, Crossover, Double-Blind Clinical Trial.

    Published in:
    Nutrients, 2025, v. 17, n. 9, p. 1491, doi. 10.3390/nu17091491
    By:
    • Di Minno, Alessandro;
    • Morone, Maria Vittoria;
    • Buccato, Daniele Giuseppe;
    • De Lellis, Lorenza Francesca;
    • Ullah, Hammad;
    • Piccinocchi, Roberto;
    • Cordara, Marcello;
    • Larsen, Danaé S.;
    • Di Guglielmo, Antonietta;
    • Baldi, Alessandra;
    • Piccinocchi, Gaetano;
    • Xiao, Xiang;
    • Sacchi, Roberto;
    • Daglia, Maria
    Publication type:
    Article
    8
    9
    10
    11
    12

    Social Pharmacology and its impact on clinics.

    Published in:
    Indian Journal of Pharmacology, 2021, v. 53, n. 6, p. 437, doi. 10.4103/ijp.ijp_867_21
    By:
    • Bansal, Seema;
    • Mahendiratta, Saniya;
    • Prakash, Ajay;
    • Medhi, Bikash
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.

    Published in:
    2012
    By:
    • Chao, Joseph;
    • Synold, Timothy;
    • Morgan, Robert;
    • Kunos, Charles;
    • Longmate, Jeff;
    • Lenz, Heinz-Josef;
    • Lim, Dean;
    • Shibata, Stephen;
    • Chung, Vincent;
    • Stoller, Ronald;
    • Belani, Chandra;
    • Gandara, David;
    • McNamara, Mark;
    • Gitlitz, Barbara;
    • Lau, Derick;
    • Ramalingam, Suresh;
    • Davies, Angela;
    • Espinoza-Delgado, Igor;
    • Newman, Edward;
    • Yen, Yun
    Publication type:
    Report
    50